Navigation Links
Notice Begins Announcing Pendency of a Class Action Regarding MetLife
Date:7/21/2009

NEW YORK, July 21 /PRNewswire/ -- The notice process has begun in a pending class action against MetLife. The class action involves MetLife's April 2000 conversion from a mutual insurance company to a stock company. The nationwide class action certified by the Federal Court in New York includes more than 8.6 million current and former MetLife policyholders.

The notice of the class action will be mailed to more than 5 million current and former policyholders. The notice will also be published in two national newspapers. A more detailed notice is available at www.insuranceclassaction.net. Additional information is also at 800-961-8147.

The text of the mailed notice is set out below.

    ------------------------------------------------------------
    United States District Court
    Eastern District of New York

    In Re MetLife Demutualization Litigation
    00cv2258 (TCP) (AKT)

NOTICE OF CLASS ACTION

METROPOLITAN LIFE INSURANCE COMPANY ("MetLife Co.") POLICYHOLDERS WHO RECEIVED IN METLIFE CO.'S DEMUTUALIZATION AT LEAST (a) 11 TRUST INTERESTS OR (b) $156.75 IN CASH OR POLICY CREDITS.

YOU MAY BE A CLASS MEMBER IN THIS LAWSUIT AND YOUR RIGHTS COULD BE AFFECTED.

This notice describes (1) this class action lawsuit; (2) the class definition; (3) your right to share in any judgment or settlement, and the binding effect on you of any judgment or settlement if you do not exclude yourself from the class; (4) your right to be excluded from the class and how to exclude yourself; and (5) how to get more information.

This Lawsuit In April 2000, Metropolitan Life Insurance Company ("MetLife Co.") converted from a mutual insurance company to a stock company, called "demutualization." The suit is against MetLife Co. and MetLife, Inc. ("Defendants") by policyholders in the demutualization ("Plaintiffs"). Plaintiffs allege Defendants sent policyholders an information package that omitted material facts and contained false statements, to win the policyholders' vote to demutualize. Plaintiffs allege Defendants violated certain federal securities laws and damaged class members. Defendants deny plaintiffs' claims and are contesting the suit. Defendants believe they did not omit material information or make false statements to policyholders, and that class members were not damaged.

Class Members You received this notice because you may be a class member. In a class action, claims common to a group, called class members, are litigated together. The results bind all class members. Class members' rights will be affected by this lawsuit.

You are a class member if you received in MetLife Co.'s demutualization (a) 11 or more trust interests in MetLife, Inc. stock or (b) cash payment or policy credits of $156.75 or more.

Remaining a class member If you are a class member and do not exclude yourself (as described below), you will remain a class member. You will be represented by Lead Plaintiffs and Lead Counsel, Jared Stamell, Esq. You will share in any judgment and be bound by the Court's decisions, whether favorable or unfavorable. You will not be personally liable for attorneys' fees or other expenses. You may not bring your own suit for the same claims. (If you wish, you may be represented in this class action by your attorney at your own expense.)

Excluding yourself You can exclude yourself from the class. If you exclude yourself, you will not share in any judgment in the case or be bound by the Court's decisions, and may pursue your own claim against Defendants individually, at your own expense.

TO EXCLUDE YOURSELF, YOU MUST MAIL BY September 8, 2009 a signed, dated statement (with your name, the policy owner's name (if different from your name), policy number, your address and telephone number) saying you exclude yourself from the MetLife Demutualization Litigation to: MetLife Demutualization Litigation, Notice Administrator, c/o Gilardi & Co LLC, P.O. Box 808054, Petaluma, CA 94975-8054

More Information This notice does not describe all the lawsuit's details. All papers filed in this case can be inspected at: Clerk, U.S. District Court, 100 Federal Plaza, Central Islip, NY 11722. Additional information, including a more detailed notice, is at: WWW.INSURANCECLASSACTION.NET

DO NOT ADDRESS QUESTIONS TO THE CLERK OF THE COURT OR THE JUDGE.

DO NOT CALL METLIFE OR YOUR AGENT ABOUT THIS NOTICE OR THE CASE.

FOR QUESTIONS VISIT WWW.INSURANCECLASSACTION.NET OR CALL 800-961-8147.

    ------------------------------------------------------------
    CONTACT:  STAMELL & SCHAGER
              JARED B. STAMELL, 212-566-4047


'/>"/>
SOURCE Law firm of Stamell & Schager, LLP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Vermillion, Inc. Announces Receipt of Notice of Noncompliance From Nasdaq
2. Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market
3. Summary Notice of Class Action in Re McKesson HBOC, Inc. Securities Litigation
4. Innocoll Receives Intends to Grant Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology
5. ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent
6. Medifast Receives Notice Regarding NYSE Listing
7. Melanomas may appear noticeably different than other moles
8. Putting the Medical Profession on Notice!: Widow Tells Tragic Story of How Her Husband Died Due to Misdiagnosis and Mistreatment
9. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
10. GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
11. Politics has taken notice of science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... FL (PRWEB) , ... February 05, 2016 , ... ... the largest domestic franchisees of Popeyes Louisiana Kitchen restaurants, launched the 14th annual ... awareness for kids and adults with muscular dystrophy, ALS and related diseases that ...
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President ... have signed a joint enrollment and degree completion agreement. The agreement, which ... baccalaureate degrees at FHU|Dickson. , The agreement allows students to be jointly ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , official operators of ... direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in the picturesque ... , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are thrilled to ...
(Date:2/5/2016)... ... February 05, 2016 , ... Regular gym users know the routine: each ... longer to access the treadmills. It’s a predictable trend. After the excesses of November ... get in shape by joining gyms, starting new walking or running routines, or signing ...
(Date:2/5/2016)... WA (PRWEB) , ... February 05, 2016 , ... ... firm, ranked #3 in the 2015 Best in KLAS: Software & Services for ... The annual Best in KLAS report independently ranks vendor performance by healthcare executives, ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)...  LivaNova, PLC, Hersteller des VNS-Therapie ® ... Titel „Epilepsy Around the World" (Epilepsie auf ... gegenüber ein größeres Bewusstsein gefördert werden soll ... Epilepsie auf dem Internationalen Epilepsietag zu einem ... der neuen Infografik sollen wichtige Statistiken zur ...
(Date:2/5/2016)... Calif. , Feb. 5, 2016  Syneron ... global aesthetic device company, announced today that ... Candela North America, is scheduled to participate in ... Healthcare Conference on February 11, 2016 in ... will allow institutional investors to meet with the ...
(Date:2/5/2016)... 5, 2016  Aralez Pharmaceuticals Inc. ("Aralez") today announced ... ("POZEN") and Tribute Pharmaceuticals Canada Inc. ("Tribute") following approval of ... Tribute. The combined company will operate under Aralez Pharmaceuticals ... in Canada , Ireland ... . Under the terms of the Agreement and Plan ...
Breaking Medicine Technology: